fda indications for glp 1 GLP-1 Drug Expansion—FDA Pathways New Is GLP-1 FDA Approved? Medication

10.1016/j.neuron.2014.12.037 Neuron 84 KanthasamyA.JinH.CharliA.VellareddyA.KanthasamyA

To understand the role of Hcy in protein modification in humans more adequate analytical tools are required

In follow-up from the STEP 1 trial on semaglutide, average weight loss on semaglutide was 17.3% at week 68

By when could we expect the study details to be shared publicly

Multiple studies have identified elevated Candida-specific antibodies in cohorts of patients meeting the diagnostic criteria for Chronic Fatigue Syndrome (CFS/ME), and several clinical trials have demonstrated significant CFS symptom reduction following structured Candida treatment